BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 12, 2005
View Archived Issues
DNA Beats Consensus With Avastin, Herceptin Growth
Once again beating consensus estimates, Genentech Inc. reported a strong third quarter driven by better-than-expected sales of Avastin and Herceptin, two products that are increasingly being prescribed off-label. (BioWorld Today)
Read More
CepTor Adding $20M To Test Myodur In Muscular Dystrophy
Read More
Antigenics Reports Positive Data From Oncophage Trial
Read More
VIRxSYS Series F Raises $31M To Boost HIV Drug
Read More
Praecis Continues Cost-Cutting Efforts, Sells Research Facility
Read More
Other News To Note
Read More
Appointments And Advancements
Read More